Zymergen Inc. announced in connection with the August 2022 Reduction in Force, Zach Serber, the company's co-founder and chief science officer and a member of the company's board of directors, will be stepping down from his position as Chief Science Officer, effective as of September 22, 2022. Dr. Serber has agreed to continue through such date in order to facilitate a smooth and orderly transition of his responsibilities and is expected to remain on the company's board of directors following his cessation of employment.